speb/financial-data huggingface dataset:
Financial ratios for SGRY — quarterly report dated 2025-09-30
Total revenue: 821500000
Gross profit: 195300000
Operating income: 135100000
Net income: 25300000
Capital expenditures: 19800000
Operating cash flow: 83600000
Depreciation & amortization: 39500000
Net tangible assets: -3405100000
Owner earnings: 45000000
Return on net tangible assets (%): -1.3215470911280138
Capex to operating income (%): 14.655810510732792
Buffett classification: The Great
Stock price: 21.64
P/E ratio: 40.49006903690987
Shares outstanding: 130788162
Book value: 3553000000
P/B ratio: 0.7965819942808894
Market cap (USD): 2830255825.6800003
Debt to equity: 1.0895581198986772
Current ratio: 1.8808873720136519
Quick ratio: 1.7233788395904437
Effective tax rate (%): 17.857142857142858
Interest coverage ratio: 1.8037383177570094
COGS to revenue (%): 76.22641509433963
SG&A to revenue (%): 2.7267194157029824
Free cash flow (dilution-adjusted): 61200000
Buyback yield (%): 0
Retained earnings: -800200000
Inventory turnover: 6.784398699891658
Receivables turnover: 1.4180907992404626
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8354481971578402
FCF margin (%): 7.449786975045648
Revenue growth (%): -0.5688695231178892
Rule of 40 score: 6.880917451927759
Financial ratios for SGRY — annual report dated 2025-12-31
Total revenue: 3308700000
Gross profit: 765000000
Operating income: 470800000
Net income: 98900000
Capital expenditures: 32200000
Operating cash flow: 274300000
Depreciation & amortization: 176000000
Net tangible assets: -3522700000
Owner earnings: 242700000
Return on net tangible assets (%): -6.889601725948847
Capex to operating income (%): 6.839422259983008
Buffett classification: The Great
Stock price: 15.45
P/E ratio: 20.431517723963598
Shares outstanding: 130788162
Book value: 3526800000
P/B ratio: 0.5729491615345356
Market cap (USD): 2020677102.8999999
Debt to equity: 1.1412044913235795
Current ratio: 1.869536961819659
Quick ratio: 1.712591389114541
Effective tax rate (%): 15.397775876817793
Interest coverage ratio: 1.727072633895818
COGS to revenue (%): 76.87913682110799
SG&A to revenue (%): 3.5724000362680206
Free cash flow (dilution-adjusted): 180800000
Buyback yield (%): 0
Retained earnings: -815200000
Inventory turnover: 26.332298136645964
Receivables turnover: 5.4943540352042515
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.273819994136617
FCF margin (%): 5.464381781364282
Revenue growth (%): 6.242173201040362
Rule of 40 score: 11.706554982404644
Financial ratios for SGRY — quarterly report dated 2025-12-31
Total revenue: 885000000
Gross profit: 212200000
Operating income: 124800000
Net income: 29000000
Capital expenditures: 9200000
Operating cash flow: 103400000
Depreciation & amortization: 59900000
Net tangible assets: -3522700000
Owner earnings: 79700000
Return on net tangible assets (%): -2.262469128793255
Capex to operating income (%): 7.371794871794872
Buffett classification: The Great
Stock price: 15.45
P/E ratio: 20.431517723963598
Shares outstanding: 130788162
Book value: 3526800000
P/B ratio: 0.5729491615345356
Market cap (USD): 2020677102.8999999
Debt to equity: 1.1412044913235795
Current ratio: 1.869536961819659
Quick ratio: 1.712591389114541
Effective tax rate (%): 31.92488262910798
Interest coverage ratio: 1.8461538461538463
COGS to revenue (%): 76.0225988700565
SG&A to revenue (%): 2.6779661016949152
Free cash flow (dilution-adjusted): 92800000
Buyback yield (%): 0
Retained earnings: -815200000
Inventory turnover: 6.9648033126294
Receivables turnover: 1.469611424775822
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6630686815383384
FCF margin (%): 10.48587570621469
Revenue growth (%): 7.72976262933658
Rule of 40 score: 18.21563833555127
Financial ratios for TC.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 14162204.724409448
Buffett classification: The Gruesome
Stock price: 83.62992125984252
Shares outstanding: 11149173
Market cap (USD): 932404460.1023622
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TC.TO — annual report dated 2022-12-31
Total revenue: 236133823.52941173
Gross profit: 57535294.11764705
Operating income: -22941911.76470588
Net income: -20272794.117647056
Capital expenditures: 100522058.8235294
Operating cash flow: 14614705.88235294
Depreciation & amortization: 29103676.470588233
Net tangible assets: -54075735.294117644
Owner earnings: -91691176.47058824
Buffett classification: The Gruesome
Stock price: 33.845588235294116
Shares outstanding: 11149173
Book value: 71071323.52941173
P/B ratio: 5.309459565163415
Market cap (USD): 377350318.5220588
Debt to equity: 2.648644174762305
Current ratio: 0.9029220623947202
Quick ratio: 0.8642162931946076
Interest coverage ratio: -2.1388127227858518
COGS to revenue (%): 75.6344545403591
R&D to revenue (%): 4.417671933288078
SG&A to revenue (%): 26.400159431030513
Free cash flow (dilution-adjusted): -92069852.94117646
Buyback yield (%): 0
Retained earnings: 41102205.88235294
Inventory turnover: 33.34623833058759
Receivables turnover: 12.335484366597525
Capitalized R&D asset: 10431617.647058822
ROCI (R&D-adjusted, %): -4.4306106022476035
FCF margin (%): -38.9905400103381
Rule of 40 score: -38.9905400103381
Financial ratios for TC.TO — annual report dated 2023-12-31
Total revenue: 257073484.84848484
Gross profit: 50505303.03030303
Operating income: -48221212.12121212
Net income: -72876515.15151514
Capital expenditures: 69738636.36363636
Operating cash flow: -3614393.9393939395
Depreciation & amortization: 35803030.303030305
Net tangible assets: -113650757.57575756
Owner earnings: -106812121.21212119
Buffett classification: The Gruesome
Stock price: 27.14393939393939
Shares outstanding: 11149173
Book value: 7481060.606060624
P/B ratio: 40.453151249620156
Market cap (USD): 302632476.20454544
Debt to equity: 46.268455696202416
Current ratio: 1.2057007762949425
Quick ratio: 1.1719967617127163
Interest coverage ratio: -1.3760809408509165
COGS to revenue (%): 80.35374863336448
R&D to revenue (%): 5.663101872180162
SG&A to revenue (%): 29.826396767814888
Free cash flow (dilution-adjusted): -79915151.51515152
Buyback yield (%): 11.444524698479231
Retained earnings: -30528787.87878788
Inventory turnover: 40.18125552608311
Receivables turnover: 13.946120335360842
Capitalized R&D asset: 21547517.156862743
ROCI (R&D-adjusted, %): -8.861410361927016
Rosenberg metric: -0.6739118826240833
FCF margin (%): -31.08650102994958
Revenue growth (%): 8.867709422604154
Rule of 40 score: -22.218791607345427
Financial ratios for TC.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 7056296.296296296
Buffett classification: The Gruesome
Stock price: 20.807407407407407
Shares outstanding: 11149173
Market cap (USD): 231985384.86666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TC.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 7438461.538461539
Buffett classification: The Gruesome
Stock price: 17.37062937062937
Shares outstanding: 11149173
Market cap (USD): 193668151.97202796
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TC.TO — annual report dated 2024-12-31
Total revenue: 253339160.83916086
Gross profit: 58062237.762237765
Operating income: -25407692.307692308
Net income: -76825174.82517482
Capital expenditures: 39103496.503496505
Operating cash flow: -13807692.307692308
Depreciation & amortization: 31902097.902097903
Net tangible assets: -175150349.65034965
Owner earnings: -84026573.42657343
Buffett classification: The Gruesome
Stock price: 17.37062937062937
Shares outstanding: 11149173
Book value: -66643356.64335662
Market cap (USD): 193668151.97202796
Debt to equity: -5.384270724029383
Current ratio: 1.0276756183356601
Quick ratio: 1.0077858004213138
Interest coverage ratio: -0.6674811235831205
COGS to revenue (%): 77.08122282796216
R&D to revenue (%): 5.141674142571251
SG&A to revenue (%): 26.623421433993517
Free cash flow (dilution-adjusted): -58602097.9020979
Buyback yield (%): 0
Retained earnings: -105005594.40559441
Inventory turnover: 70.25056603773585
Receivables turnover: 17.17350082958047
Capitalized R&D asset: 26222391.28273687
ROCI (R&D-adjusted, %): -6.006755961694306
Rosenberg metric: 0.5190796610373029
FCF margin (%): -23.13187495686978
Revenue growth (%): -1.4526290066534624
Rule of 40 score: -24.584503963523243
Financial ratios for TC.TO — quarterly report dated 2025-03-31
Total revenue: 66160139.86013986
Gross profit: 16455244.755244756
Operating income: -1421678.3216783218
Net income: -10582517.482517483
Capital expenditures: 3126573.426573427
Operating cash flow: -7867832.167832168
Depreciation & amortization: 8158041.9580419585
Net tangible assets: -183369930.06993008
Owner earnings: -5551048.951048952
Buffett classification: The Gruesome
Stock price: 17.04895104895105
Shares outstanding: 11149173
Book value: -75705594.40559447
Market cap (USD): 190081704.71328673
Debt to equity: -4.76119306477983
Current ratio: 1.0078974369604194
Quick ratio: 0.9876667323059065
Interest coverage ratio: -0.1438986409966025
COGS to revenue (%): 75.1281590546354
R&D to revenue (%): 4.658119206417995
SG&A to revenue (%): 21.385914659281887
Free cash flow (dilution-adjusted): -12722377.622377623
Buyback yield (%): 0
Retained earnings: -115588111.88811189
Inventory turnover: 18.206454918032787
Receivables turnover: 3.9185304837640826
Capitalized R&D asset: 3081818.181818182
ROCI (R&D-adjusted, %): 0.16355224635847762
FCF margin (%): -19.229671595725563
Rule of 40 score: -19.229671595725563
Financial ratios for TC.TO — quarterly report dated 2025-06-30
Total revenue: 71870802.91970803
Gross profit: 16138686.13138686
Operating income: -3406569.343065693
Net income: -11413868.613138685
Capital expenditures: 5256934.3065693425
Operating cash flow: 4792700.729927007
Depreciation & amortization: 8506569.343065692
Net tangible assets: -199987591.2408759
Owner earnings: -8164233.576642335
Buffett classification: The Gruesome
Stock price: 19.635036496350363
Shares outstanding: 11149173
Book value: -88821897.81021893
Market cap (USD): 218914418.75912407
Debt to equity: -4.28714067353681
Current ratio: 1.0552426429539836
Quick ratio: 1.0380762022489833
Interest coverage ratio: -0.3314395284425822
COGS to revenue (%): 77.54486456841656
R&D to revenue (%): 4.411809512202553
SG&A to revenue (%): 21.942252419690643
Free cash flow (dilution-adjusted): 1094160.5839416059
Buyback yield (%): 0
Retained earnings: -132064233.57664232
Inventory turnover: 22.1698606271777
Receivables turnover: 4.028105056455573
Capitalized R&D asset: 5235621.101526211
ROCI (R&D-adjusted, %): -0.5792209278389314
Rosenberg metric: -0.10271813753501075
FCF margin (%): 1.5223992768857337
Revenue growth (%): 8.631576462263082
Rule of 40 score: 10.153975739148816
Financial ratios for TC.TO — quarterly report dated 2025-09-30
Total revenue: 70905035.97122303
Gross profit: 17396402.877697844
Operating income: -2027338.129496403
Net income: -16560431.65467626
Capital expenditures: 2543884.8920863313
Operating cash flow: 1103597.1223021583
Depreciation & amortization: 8256834.532374102
Net tangible assets: -212551798.5611511
Owner earnings: -10847482.01438849
Buffett classification: The Gruesome
Stock price: 18.50359712230216
Shares outstanding: 11149173
Book value: -103639568.34532374
Market cap (USD): 206299805.43884894
Debt to equity: -3.708334779500066
Current ratio: 1.073976221928666
Quick ratio: 1.0533027669121917
Interest coverage ratio: -0.19531466592736346
COGS to revenue (%): 75.46520830373993
R&D to revenue (%): 4.750502242334463
SG&A to revenue (%): 21.84703423364922
Free cash flow (dilution-adjusted): -2664748.201438849
Buyback yield (%): 0
Retained earnings: -146724460.4316547
Inventory turnover: 18.492541024365988
Receivables turnover: 3.515157999857337
Capitalized R&D asset: 6509783.279945387
ROCI (R&D-adjusted, %): -0.47159250531900393
Rosenberg metric: 0.3966556036938419
FCF margin (%): -3.7581931451531077
Revenue growth (%): -1.3437542218137297
Rule of 40 score: -5.101947366966837
Financial ratios for TC.TO — quarterly report dated 2025-12-31
Total revenue: 72021897.81021897
Gross profit: 17614598.540145986
Operating income: -6659124.08759124
Net income: -16080291.970802918
Capital expenditures: 2849635.03649635
Operating cash flow: -1902919.7080291968
Depreciation & amortization: 8357664.233576641
Net tangible assets: -229425547.44525546
Owner earnings: -10572262.773722626
Buffett classification: The Gruesome
Stock price: 22.189781021897808
Shares outstanding: 11149173
Book value: -119854014.59854013
Market cap (USD): 247397707.44525546
Debt to equity: -3.3177283800243607
Current ratio: 0.6146410553616987
Quick ratio: 0.6029228846310986
Interest coverage ratio: -0.6272258508078378
COGS to revenue (%): 75.5427181514138
R&D to revenue (%): 4.439039221647917
SG&A to revenue (%): 28.261883044491743
Free cash flow (dilution-adjusted): -7172262.773722627
Buyback yield (%): 0
Retained earnings: -164946715.32846713
Inventory turnover: 19.25051652892562
Receivables turnover: 4.010160536476326
Capitalized R&D asset: 6500236.622380927
ROCI (R&D-adjusted, %): -2.2446251968708855
Rosenberg metric: 0.06477829363582165
FCF margin (%): -9.958447349751697
Revenue growth (%): 1.575151642894913
Rule of 40 score: -8.383295706856785
Financial ratios for TC.TO — annual report dated 2025-12-31
Total revenue: 284890510.9489051
Gross profit: 68579562.04379562
Operating income: -13606569.343065692
Net income: -55342335.76642335
Capital expenditures: 1724817.518248175
Operating cash flow: -4202919.708029197
Depreciation & amortization: 33756934.30656934
Net tangible assets: -229425547.44525546
Owner earnings: -23310218.97810219
Buffett classification: The Gruesome
Stock price: 22.189781021897808
Shares outstanding: 11149173
Book value: -119854014.59854013
Market cap (USD): 247397707.44525546
Debt to equity: -3.3177283800243607
Current ratio: 0.6146410553616987
Quick ratio: 0.6029228846310986
Interest coverage ratio: -0.32599989507004073
COGS to revenue (%): 75.92774788624135
R&D to revenue (%): 4.563925185754547
SG&A to revenue (%): 23.380988982833717
Free cash flow (dilution-adjusted): -22056204.379562043
Buyback yield (%): 0
Retained earnings: -164946715.32846713
Inventory turnover: 76.53564049586777
Receivables turnover: 15.862629546840076
Capitalized R&D asset: 26533775.44535756
ROCI (R&D-adjusted, %): -4.432458781148357
Rosenberg metric: 0.8074179268066638
FCF margin (%): -7.741993338457596
Revenue growth (%): 12.454193818765932
Rule of 40 score: 4.7122004803083355
Financial ratios for TEI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.32
Shares outstanding: 47228418
Market cap (USD): 204026765.76000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TEI — annual report dated 2022-12-31
Total revenue: -57725962
Net income: -58000199
Capital expenditures: 0
Operating cash flow: 33508731
Depreciation & amortization: 48886
Net tangible assets: 272330119
Owner earnings: -57951313
Return on net tangible assets (%): -21.279803061371997
Buffett classification: The Gruesome
Stock price: 3.65
Shares outstanding: 47228418
Book value: 272330119
P/B ratio: 0.6329954480723449
Market cap (USD): 172383725.7
Debt to equity: 0.13219250273231806
Free cash flow (dilution-adjusted): 33508731
Buyback yield (%): 1.2510600935457101
Retained earnings: -248154687
Receivables turnover: -8.01187528192032
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TEI — annual report dated 2023-12-31
Total revenue: 35419030
Net income: 34862496
Capital expenditures: 0
Operating cash flow: 14032012
Depreciation & amortization: 0
Net tangible assets: 278679506
Owner earnings: 34862496
Return on net tangible assets (%): 12.509888689123771
Buffett classification: The Gruesome
Stock price: 3.79
P/E ratio: 5.134334162992804
Shares outstanding: 47228418
Book value: 278679506
P/B ratio: 0.6422994887180545
Market cap (USD): 178995704.22
Debt to equity: 0.17941757080622928
COGS to revenue (%): 0
SG&A to revenue (%): 1.5244488626594235
Free cash flow (dilution-adjusted): 14032012
Buyback yield (%): 0.9832928715634179
Retained earnings: -227001731
Receivables turnover: 4.1475638718323165
Capitalized R&D asset: 0
FCF margin (%): 39.6171549587891
Rule of 40 score: 39.6171549587891
Financial ratios for TEI — annual report dated 2024-12-31
Total revenue: 15691249
Net income: 15199326
Capital expenditures: 0
Operating cash flow: -10461928
Net tangible assets: 266958634
Owner earnings: 15199326
Return on net tangible assets (%): 5.6935135501180305
Buffett classification: The Gruesome
Stock price: 4.24
P/E ratio: 13.174827115360248
Shares outstanding: 47228418
Book value: 266958634
P/B ratio: 0.7501105670176602
Market cap (USD): 200248492.32000002
Debt to equity: 0.2434834154867604
COGS to revenue (%): 0
SG&A to revenue (%): 2.960924270591844
Free cash flow (dilution-adjusted): -10461928
Buyback yield (%): 0
Retained earnings: -234041839
Receivables turnover: 1.6238771664201894
Capitalized R&D asset: 0
FCF margin (%): -66.67364720297282
Revenue growth (%): -55.69825317068254
Rule of 40 score: -122.37190037365536
Financial ratios for TEI — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 266958634
Buffett classification: The Gruesome
Stock price: 4.24
Shares outstanding: 47228418
Book value: 266958634
P/B ratio: 0.7501105670176602
Market cap (USD): 200248492.32000002
Debt to equity: 0.2434834154867604
Buyback yield (%): 0
Retained earnings: -234041839
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TEI — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 300254495
Buffett classification: The Gruesome
Stock price: 5.23
Shares outstanding: 47228418
Book value: 300254495
P/B ratio: 0.8226508853431154
Market cap (USD): 247004626.14000002
Debt to equity: 0.21648302051231572
Buyback yield (%): 0
Retained earnings: -200745978
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TLNC — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 244772174
Buffett classification: The Gruesome
Stock price: 10.11
Shares outstanding: 25679000
Book value: 244772174
P/B ratio: 1.060638085438584
Market cap (USD): 259614690
Debt to equity: 0
Current ratio: 22.948905222918057
Quick ratio: 22.948905222918057
Buyback yield (%): 0
Retained earnings: -7241716
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TLNC — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 244772174
Buffett classification: The Gruesome
Stock price: 10.11
Shares outstanding: 25679000
Book value: 244772174
P/B ratio: 1.060638085438584
Market cap (USD): 259614690
Debt to equity: 0
Current ratio: 22.948905222918057
Quick ratio: 22.948905222918057
Buyback yield (%): 0
Retained earnings: -7241716
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UFCS — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 5861000
Buffett classification: The Gruesome
Stock price: 20.92
Shares outstanding: 25656166
Market cap (USD): 536726992.72
Buyback yield (%): 0.4523715097121341
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UFCS — annual report dated 2022-12-31
Total revenue: 988216000
Net income: 15031000
Capital expenditures: 2137000
Operating cash flow: -1251000
Depreciation & amortization: 7670000
Net tangible assets: 734790000
Owner earnings: 20564000
Return on net tangible assets (%): 2.7986227357476285
Buffett classification: The Gruesome
Stock price: 25.21
P/E ratio: 43.03053322200785
Shares outstanding: 25656166
Book value: 740114000
P/B ratio: 0.8739085395763356
Market cap (USD): 646791944.86
Debt to equity: 0.06755716011317175
Effective tax rate (%): -24.45971681709034
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -6214000
Buyback yield (%): 0
Retained earnings: 620555000
Receivables turnover: 1.7395106495335328
Capitalized R&D asset: 0
FCF margin (%): -0.6288098958122516
Rule of 40 score: -0.6288098958122516
Financial ratios for UFCS — annual report dated 2023-12-31
Total revenue: 1098331000
Net income: -29700000
Capital expenditures: 10886000
Operating cash flow: 171736000
Depreciation & amortization: 10508000
Net tangible assets: 729130000
Owner earnings: -30078000
Return on net tangible assets (%): -4.12519029528342
Buffett classification: The Gruesome
Stock price: 19.08
Shares outstanding: 25656166
Book value: 733745000
P/B ratio: 0.6671522767173882
Market cap (USD): 489519647.28
Debt to equity: 0.06814356486245221
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 157604000
Buyback yield (%): 0.05924174884733954
Retained earnings: 574691000
Receivables turnover: 1.5479850547480491
Capitalized R&D asset: 0
FCF margin (%): 14.349408329547286
Revenue growth (%): 11.142806835752507
Rule of 40 score: 25.492215165299793
Financial ratios for UFCS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.29
Shares outstanding: 25656166
Market cap (USD): 520563608.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UFCS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.73
Shares outstanding: 25656166
Market cap (USD): 711445483.1800001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UFCS — annual report dated 2024-12-31
Total revenue: 1251860000
Net income: 61957000
Capital expenditures: 11870000
Operating cash flow: 340304000
Depreciation & amortization: 10904000
Net tangible assets: 777625000
Owner earnings: 60991000
Return on net tangible assets (%): 7.843240636553609
Buffett classification: The Gruesome
Stock price: 27.73
P/E ratio: 11.482891088658263
Shares outstanding: 25656166
Book value: 781531000
P/B ratio: 0.9103227935680095
Market cap (USD): 711445483.1800001
Debt to equity: 0.14978164653737344
Effective tax rate (%): 19.571877352857182
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 322917000
Buyback yield (%): 0
Retained earnings: 620436000
Receivables turnover: 1.799140569983185
Capitalized R&D asset: 0
FCF margin (%): 25.794977074113717
Revenue growth (%): 13.978390849388756
Rule of 40 score: 39.77336792350248
Financial ratios for UFCS — quarterly report dated 2025-03-31
Total revenue: 331111000
Net income: 17700000
Capital expenditures: 2495000
Operating cash flow: 35674000
Depreciation & amortization: 2496000
Net tangible assets: 847150000
Owner earnings: 17701000
Return on net tangible assets (%): 2.0894764799622263
Buffett classification: The Gruesome
Stock price: 28.88
P/E ratio: 10.465396526553672
Shares outstanding: 25656166
Book value: 817662000
P/B ratio: 0.9061813733303002
Market cap (USD): 740950074.0799999
Debt to equity: 0
Effective tax rate (%): 19.007961929166285
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 31421000
Buyback yield (%): 0.09879208135701817
Retained earnings: 634002000
Capitalized R&D asset: 0
FCF margin (%): 9.489566942807699
Rule of 40 score: 9.489566942807699
Financial ratios for UFCS — quarterly report dated 2025-06-30
Total revenue: 336579000
Net income: 22947000
Capital expenditures: 1738000
Operating cash flow: 53390000
Depreciation & amortization: 2496000
Net tangible assets: 842116000
Owner earnings: 23705000
Return on net tangible assets (%): 2.81493285960604
Buffett classification: The Gruesome
Stock price: 28.29
P/E ratio: 17.856494603291754
Shares outstanding: 25656166
Book value: 845668000
P/B ratio: 0.8582717285506841
Market cap (USD): 725812936.14
Debt to equity: 0.1385378186238571
Effective tax rate (%): 21.419765769467844
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 49711000
Buyback yield (%): 0.0669594017688129
Retained earnings: 653026000
Receivables turnover: 0.439129305947142
Capitalized R&D asset: 0
FCF margin (%): 14.769489480924241
Revenue growth (%): 1.6514099501375672
Rule of 40 score: 16.42089943106181
Financial ratios for UFCS — quarterly report dated 2025-09-30
Total revenue: 354018000
Net income: 39190000
Capital expenditures: 1558000
Operating cash flow: 60847000
Depreciation & amortization: 2821000
Net tangible assets: 895337000
Owner earnings: 40453000
Return on net tangible assets (%): 4.518187006680166
Buffett classification: The Gruesome
Stock price: 30.15
P/E ratio: 9.688908712752232
Shares outstanding: 25656166
Book value: 898711000
P/B ratio: 0.8607142951404845
Market cap (USD): 773533404.9
Debt to equity: 0.16259731993933535
Effective tax rate (%): 19.488043388939108
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 56973000
Buyback yield (%): 0.12733774569533138
Retained earnings: 688050000
Receivables turnover: 0.4678687021004122
Capitalized R&D asset: 0
FCF margin (%): 16.09324949578835
Revenue growth (%): 5.181250167122726
Rule of 40 score: 21.274499662911076
Financial ratios for UFCS — quarterly report dated 2025-12-31
Total revenue: 366186000
Net income: 38354000
Capital expenditures: 655000
Operating cash flow: 119832000
Depreciation & amortization: 2957000
Net tangible assets: 937973000
Owner earnings: 40656000
Return on net tangible assets (%): 4.334453123917213
Buffett classification: The Gruesome
Stock price: 36.18
P/E ratio: 7.8537290138843066
Shares outstanding: 25656166
Book value: 941170000
P/B ratio: 0.9862618717978686
Market cap (USD): 928240085.88
Debt to equity: 0.1553385679526547
Effective tax rate (%): 20.43398888059082
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 116163000
Buyback yield (%): 0.08187536948261577
Retained earnings: 722321000
Receivables turnover: 0.4968872123317412
Capitalized R&D asset: 0
FCF margin (%): 31.7224033687798
Revenue growth (%): 3.4371133671169263
Rule of 40 score: 35.15951673589673
Financial ratios for UFCS — annual report dated 2025-12-31
Total revenue: 1387894000
Net income: 118191000
Capital expenditures: 6446000
Operating cash flow: 269743000
Depreciation & amortization: 10770000
Net tangible assets: 937973000
Owner earnings: 122515000
Return on net tangible assets (%): 13.061676615424963
Buffett classification: The Gruesome
Stock price: 36.18
P/E ratio: 7.8537290138843066
Shares outstanding: 25656166
Book value: 941170000
P/B ratio: 0.9862618717978686
Market cap (USD): 928240085.88
Debt to equity: 0.1553385679526547
Effective tax rate (%): 20.106667748215447
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 254268000
Buyback yield (%): 0.10697663407399666
Retained earnings: 722321000
Receivables turnover: 1.8832691055145463
Capitalized R&D asset: 0
FCF margin (%): 18.320419282740612
Revenue growth (%): 10.866550572747752
Rule of 40 score: 29.186969855488364
Financial ratios for VIVS — annual report dated 2022-03-31
Total revenue: 257000
Operating income: -11479000
Net income: -11448000
Capital expenditures: 409000
Operating cash flow: -8453000
Depreciation & amortization: 142000
Net tangible assets: 30209000
Owner earnings: -11715000
Return on net tangible assets (%): -38.77983382435698
Buffett classification: The Gruesome
Stock price: 45.12
Shares outstanding: 3494071
Book value: 30209000
P/B ratio: 5.218725661888841
Market cap (USD): 157652483.51999998
Debt to equity: 0.07226323281141382
Current ratio: 21.354302241503976
Quick ratio: 21.354302241503976
COGS to revenue (%): 0
R&D to revenue (%): 1291.8287937743191
SG&A to revenue (%): 3747.4708171206225
Free cash flow (dilution-adjusted): -11118000
Buyback yield (%): 0
Retained earnings: -307739000
Capitalized R&D asset: 3320000
ROCI (R&D-adjusted, %): -26.298262045998545
FCF margin (%): -4326.070038910506
Rule of 40 score: -4326.070038910506
Financial ratios for VIVS — annual report dated 2023-03-31
Total revenue: 370000
Operating income: -17731000
Net income: -17259000
Capital expenditures: 396000
Operating cash flow: -12408000
Depreciation & amortization: 293000
Net tangible assets: 15329000
Owner earnings: -17362000
Return on net tangible assets (%): -113.26244373409877
Buffett classification: The Gruesome
Stock price: 26.28
Shares outstanding: 3494071
Book value: 15329000
P/B ratio: 5.990226751908148
Market cap (USD): 91824185.88000001
Debt to equity: 0.11775066866723205
Current ratio: 4.643966221737946
Quick ratio: 4.643966221737946
COGS to revenue (%): 0
R&D to revenue (%): 2401.3513513513512
SG&A to revenue (%): 2456.2162162162163
Free cash flow (dilution-adjusted): -15181000
Buyback yield (%): 0
Retained earnings: -324998000
Receivables turnover: 2.4342105263157894
Capitalized R&D asset: 11109400
ROCI (R&D-adjusted, %): -46.53579038655107
FCF margin (%): -4102.972972972973
Revenue growth (%): 43.96887159533074
Rule of 40 score: -4059.0041013776427
Financial ratios for VIVS — annual report dated 2024-03-31
Total revenue: 109000
Gross profit: 109000
Operating income: -15086000
Net income: -14671000
Capital expenditures: 42000
Operating cash flow: -14653000
Depreciation & amortization: 280000
Net tangible assets: 3601000
Owner earnings: -14433000
Return on net tangible assets (%): -400.80533185226324
Buffett classification: The Gruesome
Stock price: 12.36
Shares outstanding: 3494071
Book value: 3601000
P/B ratio: 11.992979050263814
Market cap (USD): 43186717.559999995
Debt to equity: 0.3871146903637878
Current ratio: 2.1161290322580646
Quick ratio: 1.956451612903226
COGS to revenue (%): 0
R&D to revenue (%): 5044.036697247707
SG&A to revenue (%): 8847.70642201835
Free cash flow (dilution-adjusted): -16203000
Buyback yield (%): 0
Retained earnings: -339669000
Inventory turnover: 0
Receivables turnover: 3.303030303030303
Capitalized R&D asset: 12546550
ROCI (R&D-adjusted, %): -90.92163152936065
FCF margin (%): -14865.1376146789
Revenue growth (%): -70.54054054054055
Rule of 40 score: -14935.67815521944
Financial ratios for VIVS — quarterly report dated 2024-09-30
Capital expenditures: 13000
Buffett classification: The Gruesome
Stock price: 6.12
Shares outstanding: 3494071
Market cap (USD): 21383714.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIVS — quarterly report dated 2024-12-31
Total revenue: 24000
Gross profit: 22000
Operating income: -3468000
Net income: -3447000
Capital expenditures: 0
Operating cash flow: -1801000
Depreciation & amortization: 67000
Net tangible assets: 364000
Owner earnings: -3380000
Return on net tangible assets (%): -928.5714285714287
Buffett classification: The Gruesome
Stock price: 5.52
Shares outstanding: 3494071
Book value: 364000
P/B ratio: 52.987010769230764
Market cap (USD): 19287271.919999998
Debt to equity: 2.912087912087912
Current ratio: 0.7150153217568948
Quick ratio: 0.7150153217568948
Interest coverage ratio: -693.6
COGS to revenue (%): 8.333333333333332
R&D to revenue (%): 7416.666666666667
SG&A to revenue (%): 7079.166666666667
Free cash flow (dilution-adjusted): -1931000
Buyback yield (%): 0
Retained earnings: -349009000
Receivables turnover: 0.9230769230769231
Capitalized R&D asset: 1780000
ROCI (R&D-adjusted, %): -84.90261754124799
FCF margin (%): -8045.833333333333
Rule of 40 score: -8045.833333333333
Financial ratios for VIVS — annual report dated 2025-03-31
Total revenue: 144000
Gross profit: 139000
Operating income: -12616000
Net income: -2488000
Capital expenditures: 8987000
Operating cash flow: -9461000
Depreciation & amortization: 266000
Net tangible assets: 10492000
Owner earnings: -11209000
Return on net tangible assets (%): -106.83377811666031
Buffett classification: The Gruesome
Stock price: 2.24
Shares outstanding: 3494071
Book value: 10492000
P/B ratio: 0.7459701715592834
Market cap (USD): 7826719.040000001
Debt to equity: 0.08978269157453297
Current ratio: 3.246186780840246
Quick ratio: 3.246186780840246
Interest coverage ratio: -1261.6
COGS to revenue (%): 3.4722222222222223
R&D to revenue (%): 3489.5833333333335
SG&A to revenue (%): 5340.972222222222
Free cash flow (dilution-adjusted): -10006000
Buyback yield (%): 0
Retained earnings: -342157000
Receivables turnover: 4.8
Capitalized R&D asset: 11640710
ROCI (R&D-adjusted, %): -62.341554153765976
Rosenberg metric: 0.005456529647144416
FCF margin (%): -6948.611111111111
Revenue growth (%): 32.11009174311927
Rule of 40 score: -6916.501019367992
Financial ratios for VIVS — quarterly report dated 2025-03-31
Total revenue: 51000
Gross profit: 51000
Operating income: -3154000
Net income: 6852000
Capital expenditures: 9000000
Operating cash flow: -2035000
Depreciation & amortization: 61000
Net tangible assets: 10492000
Owner earnings: -2087000
Return on net tangible assets (%): -19.89134578726649
Buffett classification: The Gruesome
Stock price: 2.24
P/E ratio: 0.28556330414477527
Shares outstanding: 3494071
Book value: 10492000
P/B ratio: 0.7459701715592834
Market cap (USD): 7826719.040000001
Debt to equity: 0.08978269157453297
Current ratio: 3.246186780840246
Quick ratio: 3.246186780840246
Effective tax rate (%): 0
Interest coverage ratio: -630.8
COGS to revenue (%): 0
R&D to revenue (%): 1684.3137254901962
SG&A to revenue (%): 4592.156862745098
Free cash flow (dilution-adjusted): -2126000
Buyback yield (%): 0
Retained earnings: -342157000
Receivables turnover: 1.7
Capitalized R&D asset: 2051600
ROCI (R&D-adjusted, %): -24.48719333158498
Rosenberg metric: 0.016292134831460674
FCF margin (%): -4168.6274509803925
Revenue growth (%): 112.5
Rule of 40 score: -4056.1274509803925
Financial ratios for VIVS — quarterly report dated 2025-06-30
Total revenue: 37000
Gross profit: 37000
Operating income: -2915000
Net income: -2843000
Capital expenditures: 0
Operating cash flow: -3940000
Depreciation & amortization: 61000
Net tangible assets: 9538000
Owner earnings: -2782000
Return on net tangible assets (%): -29.167540364856364
Buffett classification: The Gruesome
Stock price: 1.47
P/E ratio: 9.139296032028469
Shares outstanding: 3494071
Book value: 9538000
P/B ratio: 0.5385074827007759
Market cap (USD): 5136284.37
Debt to equity: 0.0861815894317467
Current ratio: 4.518674136321195
Quick ratio: 4.518674136321195
Interest coverage ratio: -728.75
COGS to revenue (%): 0
R&D to revenue (%): 2705.4054054054054
SG&A to revenue (%): 5259.45945945946
Free cash flow (dilution-adjusted): -4018000
Buyback yield (%): 0
Retained earnings: -345000000
Receivables turnover: 1.15625
Capitalized R&D asset: 2163930
ROCI (R&D-adjusted, %): -26.061263135146064
Rosenberg metric: -0.01629802095459837
FCF margin (%): -10859.45945945946
Revenue growth (%): -27.450980392156865
Rule of 40 score: -10886.910439851617
Financial ratios for VIVS — quarterly report dated 2025-09-30
Total revenue: 28000
Gross profit: 28000
Operating income: -2635000
Net income: -2545000
Capital expenditures: 0
Operating cash flow: -2378000
Depreciation & amortization: 59000
Net tangible assets: 7065000
Owner earnings: -2486000
Return on net tangible assets (%): -35.18754423213022
Buffett classification: The Gruesome
Stock price: 2.92
Shares outstanding: 3494071
Book value: 7065000
P/B ratio: 1.4441171012031138
Market cap (USD): 10202687.32
Debt to equity: 0.09907997169143666
Current ratio: 3.0996325030624745
Quick ratio: 3.0996325030624745
COGS to revenue (%): 0
R&D to revenue (%): 3296.4285714285716
SG&A to revenue (%): 6200
Free cash flow (dilution-adjusted): -2450000
Buyback yield (%): 0
Retained earnings: -347545000
Receivables turnover: 0.875
Capitalized R&D asset: 1877140
ROCI (R&D-adjusted, %): -28.96232301310564
Rosenberg metric: -0.008991008991008992
FCF margin (%): -8750
Revenue growth (%): -24.324324324324326
Rule of 40 score: -8774.324324324325
Financial ratios for VIVS — quarterly report dated 2025-12-31
Total revenue: 26000
Gross profit: 26000
Operating income: -2750000
Net income: -2691000
Capital expenditures: 0
Operating cash flow: -2271000
Depreciation & amortization: 52000
Net tangible assets: 4441000
Owner earnings: -2639000
Return on net tangible assets (%): -59.42355325377168
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 3494071
Book value: 4441000
P/B ratio: 1.42406406439991
Market cap (USD): 6324268.51
Debt to equity: 0.129925692411619
Current ratio: 2.4408080808080808
Quick ratio: 2.4408080808080808
Interest coverage ratio: -687.5
COGS to revenue (%): 0
R&D to revenue (%): 4384.615384615385
SG&A to revenue (%): 6280.7692307692305
Free cash flow (dilution-adjusted): -2338000
Buyback yield (%): 0
Retained earnings: -350236000
Receivables turnover: 0.02490421455938697
Capitalized R&D asset: 2088740
ROCI (R&D-adjusted, %): -40.027949589325615
Rosenberg metric: -0.0021668472372697724
FCF margin (%): -8992.307692307691
Revenue growth (%): -7.142857142857142
Rule of 40 score: -8999.450549450548
Financial ratios for VNDA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.69
Shares outstanding: 60135562
Market cap (USD): 943526967.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VNDA — annual report dated 2022-12-31
Total revenue: 254382000
Gross profit: 230100000
Operating income: 6329000
Net income: 6275000
Capital expenditures: 679000
Operating cash flow: 31984000
Depreciation & amortization: 2733000
Net tangible assets: 508633000
Owner earnings: 8329000
Return on net tangible assets (%): 1.6375264680034523
Capex to operating income (%): 10.728393111076
Buffett classification: The Great
Stock price: 7.39
P/E ratio: 70.82100449083664
Shares outstanding: 60135562
Book value: 527198000
P/B ratio: 0.8429504724600624
Market cap (USD): 444401803.18
Debt to equity: 0.021132477740810854
Current ratio: 5.679294807296907
Quick ratio: 5.666236493284921
Effective tax rate (%): 44.469026548672566
COGS to revenue (%): 9.545486708965258
R&D to revenue (%): 33.717008278887654
SG&A to revenue (%): 53.65356039342406
Free cash flow (dilution-adjusted): 15026000
Buyback yield (%): 0
Retained earnings: -157901000
Inventory turnover: 20.33668341708543
Receivables turnover: 7.590773454285032
Capitalized R&D asset: 85770000
ROCI (R&D-adjusted, %): 10.103550695932585
FCF margin (%): 5.906864479404989
Rule of 40 score: 5.906864479404989
Financial ratios for VNDA — annual report dated 2023-12-31
Total revenue: 192640000
Gross profit: 177844000
Operating income: -13952000
Net income: 2509000
Capital expenditures: 383000
Operating cash flow: 12801000
Depreciation & amortization: 4334000
Net tangible assets: 423541000
Owner earnings: 6460000
Return on net tangible assets (%): 1.5252360456248626
Buffett classification: The Gruesome
Stock price: 4.22
P/E ratio: 101.1447077082503
Shares outstanding: 60135562
Book value: 544910000
P/B ratio: 0.46571373555266005
Market cap (USD): 253772071.64
Debt to equity: 0.017257895799306307
Current ratio: 4.936839344561387
Quick ratio: 4.921365611138351
Effective tax rate (%): 60.41962454645843
COGS to revenue (%): 7.680647840531561
R&D to revenue (%): 39.87904900332226
SG&A to revenue (%): 58.597902823920265
Free cash flow (dilution-adjusted): -1622000
Buyback yield (%): 0
Retained earnings: -155392000
Inventory turnover: 10.90346352247605
Receivables turnover: 5.640169814082857
Capitalized R&D asset: 134288900
ROCI (R&D-adjusted, %): 1.2479043527834242
Rosenberg metric: -0.6092573160778827
FCF margin (%): -0.841985049833887
Revenue growth (%): -24.271371402064613
Rule of 40 score: -25.1133564518985
Financial ratios for VNDA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.69
Shares outstanding: 60135562
Market cap (USD): 282035785.78000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VNDA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.79
Shares outstanding: 60135562
Market cap (USD): 288049341.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VNDA — annual report dated 2024-12-31
Total revenue: 198772000
Gross profit: 187458000
Operating income: -40660000
Net income: -18900000
Capital expenditures: 490000
Operating cash flow: -15757000
Depreciation & amortization: 9799000
Net tangible assets: 424450000
Owner earnings: -9591000
Return on net tangible assets (%): -2.25963010955354
Buffett classification: The Gruesome
Stock price: 4.79
Shares outstanding: 60135562
Book value: 538546000
P/B ratio: 0.5348648805858738
Market cap (USD): 288049341.98
Debt to equity: 0.022950685735294664
Current ratio: 4.389734049469399
Quick ratio: 4.372470769446195
COGS to revenue (%): 5.691948564184091
R&D to revenue (%): 37.44541484716157
SG&A to revenue (%): 73.65926790493631
Free cash flow (dilution-adjusted): -28679000
Buyback yield (%): 0
Retained earnings: -174292000
Inventory turnover: 6.555040556199304
Receivables turnover: 4.220122715016666
Capitalized R&D asset: 154206510
ROCI (R&D-adjusted, %): -6.367556437794933
Rosenberg metric: 0.12514481340223632
FCF margin (%): -14.428088463163826
Revenue growth (%): 3.1831395348837206
Rule of 40 score: -11.244948928280106
Financial ratios for VNDA — quarterly report dated 2025-03-31
Total revenue: 50041000
Gross profit: 46520000
Operating income: -41028000
Net income: -29494000
Capital expenditures: 436000
Operating cash flow: -33147000
Depreciation & amortization: 2828000
Net tangible assets: 399073000
Owner earnings: -27102000
Return on net tangible assets (%): -6.791238695677232
Buffett classification: The Gruesome
Stock price: 4.59
Shares outstanding: 60135562
Book value: 511417000
P/B ratio: 0.5397204816812895
Market cap (USD): 276022229.58
Debt to equity: 0.022965603411697302
Current ratio: 3.9251176351721946
Quick ratio: 3.906613550417136
COGS to revenue (%): 7.036230291161248
R&D to revenue (%): 71.36548030614895
SG&A to revenue (%): 100.08592953777902
Free cash flow (dilution-adjusted): -36554000
Buyback yield (%): 0
Retained earnings: -203786000
Inventory turnover: 1.8309932397295892
Receivables turnover: 1.121920050220837
Capitalized R&D asset: 35712000
ROCI (R&D-adjusted, %): -3.054680917113841
FCF margin (%): -73.04810055754281
Rule of 40 score: -73.04810055754281
Financial ratios for VNDA — quarterly report dated 2025-06-30
Total revenue: 52590000
Gross profit: 49854000
Operating income: -38503000
Net income: -27207000
Capital expenditures: 299000
Operating cash flow: -15252000
Depreciation & amortization: 1751000
Net tangible assets: 375736000
Owner earnings: -25755000
Return on net tangible assets (%): -6.854546809461963
Buffett classification: The Gruesome
Stock price: 4.72
Shares outstanding: 60135562
Book value: 486329000
P/B ratio: 0.5836375224179515
Market cap (USD): 283839852.64
Debt to equity: 0.023930302326203044
Current ratio: 3.2506729004271993
Quick ratio: 3.23281943221197
COGS to revenue (%): 6.301578246814985
R&D to revenue (%): 41.814033086138046
SG&A to revenue (%): 122.8674652975851
Free cash flow (dilution-adjusted): -17657000
Buyback yield (%): 0
Retained earnings: -230993000
Inventory turnover: 1.5278930382664822
Receivables turnover: 1.1688484875425067
Capitalized R&D asset: 45917040
ROCI (R&D-adjusted, %): -6.509229751646672
Rosenberg metric: 0.09335797491039427
FCF margin (%): -33.57482411104773
Revenue growth (%): 5.093823065086629
Rule of 40 score: -28.481001045961104
Financial ratios for VNDA — quarterly report dated 2025-09-30
Total revenue: 56258000
Gross profit: 53304000
Operating income: -31284000
Net income: -22586000
Capital expenditures: 161000
Operating cash flow: -31626000
Depreciation & amortization: 2053000
Net tangible assets: 357158000
Owner earnings: -20694000
Return on net tangible assets (%): -5.794074331248355
Buffett classification: The Gruesome
Stock price: 4.99
Shares outstanding: 60135562
Book value: 465999000
P/B ratio: 0.643942271077835
Market cap (USD): 300076454.38
Debt to equity: 0.02342279704462885
Current ratio: 3.117807754305591
Quick ratio: 3.1004835836090607
COGS to revenue (%): 5.250808773863272
R&D to revenue (%): 40.10629599345871
SG&A to revenue (%): 107.13676277151694
Free cash flow (dilution-adjusted): -33899000
Buyback yield (%): 0
Retained earnings: -253579000
Inventory turnover: 1.4466209598432909
Receivables turnover: 1.1131160839714291
Capitalized R&D asset: 49081260
ROCI (R&D-adjusted, %): -6.664021045052096
Rosenberg metric: 0.15688949522510232
FCF margin (%): -60.256319101283374
Revenue growth (%): 6.9747100209165245
Rule of 40 score: -53.28160908036685
Financial ratios for VNDA — quarterly report dated 2025-12-31
Total revenue: 57216000
Gross profit: 53383000
Operating income: -40353000
Net income: -141187000
Capital expenditures: 102000
Operating cash flow: -29417000
Depreciation & amortization: 5863000
Net tangible assets: 210097000
Owner earnings: -135426000
Return on net tangible assets (%): -64.45879760301194
Buffett classification: The Gruesome
Stock price: 8.82
Shares outstanding: 60135562
Book value: 327186000
P/B ratio: 1.621082982890466
Market cap (USD): 530395656.84000003
Debt to equity: 0.03857744524521221
Current ratio: 2.3922376379493255
Quick ratio: 2.3794794781003294
COGS to revenue (%): 6.6991750559284124
R&D to revenue (%): 50.6956096196868
SG&A to revenue (%): 110.07060961968679
Free cash flow (dilution-adjusted): -31804000
Buyback yield (%): 0
Retained earnings: -394766000
Inventory turnover: 2.0696544276457884
Receivables turnover: 1.0483344937520613
Capitalized R&D asset: 51379910
ROCI (R&D-adjusted, %): -9.076356476869847
Rosenberg metric: 0.00350130745025041
FCF margin (%): -55.58585011185683
Revenue growth (%): 1.7028689253084004
Rule of 40 score: -53.88298118654843
Financial ratios for VNDA — annual report dated 2025-12-31
Total revenue: 216105000
Gross profit: 203061000
Operating income: -151168000
Net income: -220474000
Capital expenditures: 998000
Operating cash flow: -109442000
Depreciation & amortization: 11917000
Net tangible assets: 210097000
Owner earnings: -209555000
Return on net tangible assets (%): -99.74202392228352
Buffett classification: The Gruesome
Stock price: 8.82
Shares outstanding: 60135562
Book value: 327186000
P/B ratio: 1.621082982890466
Market cap (USD): 530395656.84000003
Debt to equity: 0.03857744524521221
Current ratio: 2.3922376379493255
Quick ratio: 2.3794794781003294
COGS to revenue (%): 6.035954744221559
R&D to revenue (%): 50.563846278429466
SG&A to revenue (%): 110.10897480391478
Free cash flow (dilution-adjusted): -119914000
Buyback yield (%): 0
Retained earnings: -394766000
Inventory turnover: 7.043196544276458
Receivables turnover: 3.959562461064898
Capitalized R&D asset: 184491360
ROCI (R&D-adjusted, %): -24.369521848649104
Rosenberg metric: 0.20963039593717672
FCF margin (%): -55.48876703454339
Revenue growth (%): 8.720041052059646
Rule of 40 score: -46.768725982483744
Financial ratios for WAK.AX — annual report dated 2021-06-30
Total revenue: 909506.7669172932
Gross profit: 196860.90225563908
Operating income: -6901193.233082706
Net income: -15543832.330827067
Capital expenditures: 6013021.052631578
Depreciation & amortization: 102057.14285714286
Net tangible assets: 1601878.947368421
Owner earnings: -21454796.240601502
Return on net tangible assets (%): -1339.351907698619
Buffett classification: The Gruesome
Stock price: 0.15037593984962405
Shares outstanding: 1396356838
Book value: 1601878.9473684207
P/B ratio: 131.0826090976809
Market cap (USD): 209978471.87969923
Debt to equity: 9.573049318492993
Current ratio: 2.993339800374038
Quick ratio: 2.993339800374038
Interest coverage ratio: -0.7781803799681812
COGS to revenue (%): 78.35520202638132
R&D to revenue (%): 2.3118372016890922
SG&A to revenue (%): 461.5371133986528
Free cash flow (dilution-adjusted): -8272830.827067669
Buyback yield (%): 0
Retained earnings: -49002903.75939849
Receivables turnover: 2.1714593449597444
Capitalized R&D asset: 21026.315789473683
ROCI (R&D-adjusted, %): -41.74998255089161
FCF margin (%): -909.5953024195549
Rule of 40 score: -909.5953024195549